Newsroom

Sorted by: Latest

-

Litera Helps Cvent Legal Team Review 360 Contracts in Minutes During High-Stakes Acquisition

CHICAGO--(BUSINESS WIRE)--Litera unveils how Kira delivered the contract intelligence Cvent needed to navigate its most significant deal on a compressed timeline...
-

Jeff Man Joins Secure Ideas to Build PCI Practice and Expand Conference Presence

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Secure Ideas, the CREST-accredited penetration testing and information security consulting firm known as “Professionally Evil,” announced that veteran information security practitioner Jeff Man has joined the company. Jeff will build out the firm’s Payment Card Industry (PCI) practice and represent Secure Ideas as a speaker and keynoter at security conferences across the country. Jeff Man is one of the most recognizable figures in the information security co...
-

Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from the final analysis of the dual primary endpoint of overall survival (OS) in the subset of patients without active liver metastases (non-liver metastases, NLM) in the phase 3 STELLAR-303 pivotal trial evaluating zanzalintinib in combination with atezolizumab (Tecentriq®) versus regorafenib in previously treated non-microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC). The results sho...
-

Bayer and Iambic Collaborate to Advance Drug Discovery with AI

BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic’s AI-driven platform. The collaboration is focused on small molecule discovery. The collaboration will leverage Iambic’s AI-driven drug discovery platform, including its flagship AI technologies, Enchant & Neu...
-

Brightstar Capital Partners Acquires Erdman, Expanding Its Architecture & Design Platform into Healthcare and Senior Living

NEW YORK & MADISON, Wis.--(BUSINESS WIRE)--Brightstar Capital Partners (“Brightstar”), a middle-market private equity firm focused on control-oriented investments in business services, industrials, technology, media & telecom, and financial services companies, announced today that it has acquired Erdman, an architecture and engineering firm specializing in healthcare and senior living facilities. Erdman joins KZF Design as part of Brightstar’s architecture and design platform, which the fir...
-

Chevron Signs 20-Year Power Agreement with Microsoft for West Texas Data Center

HOUSTON--(BUSINESS WIRE)--Chevron announced a 20‑year agreement with Microsoft to develop Project Kilby, a co‑located power facility in West Texas for a Microsoft data center....
-

Applebee’s DOLLARITA® Returns This July

PASADENA, Calif.--(BUSINESS WIRE)--America, get ready to raise a glass. Applebee’s is bringing back the cocktail that broke the internet and redefined value: the legendary DOLLARITA®. For the entire month of July, guests 21+ can sip on Applebee’s signature $1 margarita – made with tequila, triple sec, and lime – available nationwide for dine-in.* “An American original, the DOLLARITA has become a true cultural icon,” said Michelle Chin, chief marketing officer at Applebee’s. “This July, we’re br...
-

Marmon Industrial Energy & Infrastructure Expands VITALink® Portfolio with Launch of VITALink® MI Cable at NFPA Conference & Expo

EAST GRANBY, Conn.--(BUSINESS WIRE)--Marmon Industrial Energy & Infrastructure Expands VITALink® Portfolio with the Launch of VITALink® MI Cable at the NFPA Conference & Expo...
-

Lemonade Brings Autonomous Car Insurance to Colorado

DENVER--(BUSINESS WIRE)--Lemonade (NYSE: LMND), the technology-driven insurance company, today announced that its Autonomous Car insurance is now available in Colorado. Lemonade Autonomous Car is a first-of-its-kind product that gives Tesla owners 50% off every mile driven using Tesla's Full Self-Driving (Supervised) technology. "Today, we're bringing Lemonade Autonomous Car to Tesla drivers in Colorado. This first-of-its-kind insurance product cuts Tesla's cost of ownership by slashing insuran...
-

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies reports on preclinical findings that demonstrate siRNA therapy kills skin cancer cells while sparing healthy cells....